📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist. (2014)

First Author: Sarvi S

Attributed to: A hub for Engineering and exploiting the stem cell niche funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-13-1541

PubMed Identifier: 24436149

Publication URI: http://europepmc.org/abstract/MED/24436149

Type: Journal Article/Review

Volume: 74

Parent Publication: Cancer research

Issue: 5

ISSN: 0008-5472